Genomic imprinting and cancer; new paradigms in the genetics of neoplasia

Toxicology Letters

Volumn 120, Issue 1-3, 2001, Pages 151-160

  Schofield, Paul N ^a   Joyce, Johanna A ^b   Lam, Wayne K ^c   Grandjean, Valerie ^a   Ferguson Smith, Anne ^a   Reik, Wolf ^d   Maher, Eamonn R ^c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d BABRAHAM INSTITUTE   (United Kingdom)

Author keywords

Ageing; Beckwith Wiedemann syndrome; CDKN1C; Chromosome 11; Epimutation; H19; Imprinting; Insulin like growth factor II; KCNQ1; Methylation; Tumour suppressor gene; Wilms' tumour

Indexed keywords

BECKWITH WIEDEMANN SYNDROME; CANCER; CARCINOGENESIS; CONFERENCE PAPER; DISEASE PREDISPOSITION; GENE EXPRESSION; GENE FUNCTION; GENOME IMPRINTING; METHYLATION; NEOPLASM; NEPHROBLASTOMA; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

AGING; BECKWITH-WIEDEMANN SYNDROME; DNA METHYLATION; GENE SILENCING; GENES, TUMOR SUPPRESSOR; GENOMIC IMPRINTING; HUMANS; INSULIN-LIKE GROWTH FACTOR II; MULTIGENE FAMILY; NEOPLASMS;

EID: 0035977865     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4274(01)00294-6     Document Type: Conference Paper

References (66)

1. Aging, methylation and cancer
2. Aging and DNA methylation in colorectal mucosa and cancer
3. Analysis of CDKN1C in Beckwith Wiedemann syndrome
4. Aberrant methylation of gene promoters in cancer - Concepts, misconcepts, and promise
5. DNA hypermethylation in tumorigenesis: Epigenetics joins genetics
6. INK4a is an early event in lung cancer and a potential biomarker for early diagnosis
7. Paternal origin of 11p15 duplications in the Beckwith-Wiedemann syndrome
8. Imprinting mutation in the Beckwith-Wiedemann syndrome leads to biallelic IGF2 expression through an H19-independent pathway
9. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer
10. Multiple mechanisms regulate imprinting of the mouse distal chromosome 7 gene cluster
11. Epigenetic modification and uniparental inheritance of H19 in Beckwith-Wiedemann syndrome
12. Deletion of a silencer element in igf2 results in loss of imprinting independent of H19
13. Loss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability
14. Multipoint analysis of human chromosome 11p15/mouse distal chromosome 7: Inclusion of H19/IGF2 in the minimal WT2 region, gene specificity of H19 silencing in Wilms' tumorigenesis and methylation hyper-dependence of H19 imprinting
15. Beckwith-Weidemann syndrome
16. Epigenotype-phenotype correlations in Beckwith-Wiedemann syndrome
17. Mtr1, a novel biallelically expressed gene in the center of the mouse distal chromosome 7 imprinting cluster, is a member of the Trp gene family
18. Methylation sequencing analysis refines the region of H19 epimutation in Wilms tumor
19. kip2 expression in vivo and in vitro: Implications for Beckwith-Wiedemann syndrome
20. KIP2 and its reduced expression in Wilms tumours
21. The cell type-specific IGF2 expression during early human development correlates to the pattern of overgrowth and neoplasia in the Beckwith-Wiedemann syndrome
22. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma
23. Targeted disruption of the human LIT1 locus defines a putative imprinting control element playing an essential role in Beckwith-Wiedemann syndrome
24. Isolated hemihyperplasia (hemihypertrophy): Report of a prospective multicenter study of the incidence of neoplasia and review
25. Wilms tumor genetics
26. Evidence for genetic heterogeneity in familial Wilms' tumor
27. Switch from monoallelic to biallelic human igf2 promoter methylation during aging and carcinogenesis
28. Cancer epigenetics comes of age
29. Imprinting of IGF2 and H19: Lack of reciprocity in sporadic Beckwith-Wiedemann syndrome
30. Genomic imprinting and cancer
31. Biallelic expression of the H19 and IGF2 genes in hepatocellular carcinoma
32. Mutation and cancer: A model for Wilms' tumour of the kidney
33. KIP2) mutations in familial and sporadic Beckwith-Wiedemann syndrome (BWS) provides a novel genotype-phenotype correlation
34. KIP2 mutation in Beckwith-Wiedemann syndrome
35. Human KVLQT1 gene shows tissue specific imprinting and encompasses Beckwith-Wiedemann syndrome chromosomal rearrangements
36. Disrupted IGF2 promoter control by silencing of promoter P1 in human hepatocellular carcinoma
37. The imprinted antisense RNA at the Igf2r locus overlaps but does not imprint Mas1
38. Beckwith-Wiedemann syndrome: Imprinting in clusters revisited
39. KIP2, on chromosome 11p15
40. LIT1, an imprinted antisense RNA in the human KvLQT1 locus identified by screening for differentially expressed transcripts using monochromosomal hybrids
41. Somatic overgrowth associated with overexpression of insulin-like growth factor II
42. Epigenetic lesions at the H19 locus in Wilms' tumour patients
43. Genomic imprinting of IGF2 and H19 in human meningiomas
44. Insulin-like growth factor II is focally up-regulated and functionally involved as a second signal for oncogene-induced tumorigenesis
45. Relaxation of insulin-like growth factor II gene imprinting in Wilms' tumour
46. KIP2 are present in some cases of Beckwith-Wiedemann syndrome but are rare or absent in Wilms' tumors
47. Inactivation of WT1 in nephrogenic rests, genetic precursors to Wilms' tumour
48. Sequence conservation and variability of imprinting in the Beckwith-Wiedemann syndrome gene cluster in human and mouse
49. Identification and characterization of MTR1, a novel gene with homology to melastatin (MLSN1) and the trp gene family located in the BWS-WT2 critical region on chromosome 11p15.5 and showing allele-specific expression
50. Relaxation of imprinted genes in human cancer
51. Evidence for susceptibility genes to familial Wilms' tumour in addition to WT1, FWT1 and FWT2
52. Localization of a tumor suppressor gene in 11p15.5 using the G401 Wilms' tumor assay
53. DNA methylation: Past, present and future directions
54. An imprinted antisense RNA overlaps UBE3A and a second maternally expressed transcript
55. Gain of imprinting at chromosome 11p15: A pathogenetic mechanism identified in human hepatocarcinomas
56. A maternally methylated CpG island in KvLQT1 is associated with an antisense paternal transcript and loss of imprinting in Beckwith-Wiedemann syndrome
57. Relaxation of insulin-like growth factor 2 imprinting and discordant methylation at KvDMR1 in two first cousins affected by Beckwith-Wiedemann and Klippel-Trenaunay-Weber syndromes
58. Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumour
59. Allelic-expression imbalance of the insulin-like growth factor 2 gene in hepatocellular carcinoma and underlying disease
60. Hypermethylation of the death-associated protein (DAP) kinase promoter and aggressiveness in stage I non-small-cell lung cancer
61. KIP2 defines a new imprinted domain on chromosome 11p but is not a tumour suppressor gene in Wilms' tumour
62. Epigenetic changes encompassing the IGF2/H19 locus associated with relaxation of IGF2 imprinting and silencing of H19 in Wilms' tumor
63. KIP2 in Wilms' tumour
64. Altered transcriptional regulation of the insulin-like growth factor 2 gene in human hepatocellular carcinoma
65. Disruption of insulin-like growth factor 2 imprinting in Beckwith-Wiedemann syndrome
66. Gene expression profiles in normal and cancer cells